ASX:COHMedical Equipment
Assessing Cochlear’s Valuation After Its FY26 Earnings Guidance Downgrade
Cochlear (ASX:COH) has been in focus after a significant downgrade to its FY26 earnings guidance, with management pointing to softer demand, delayed surgeries, and Middle East disruptions as key pressures on near term performance.
See our latest analysis for Cochlear.
The share price shock from the April guidance downgrade still dominates the picture, with a 30 day share price return of 41.83% and a year to date share price return of 61.59%. The 1 year total shareholder return of 62.03% and 5...